EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Gut Microbial Metabolite Imidazole Propionate Impairs Endothelial Cell Function and Promotes the Development of Atherosclerosis

Vanasa Nageswaran iD, Alba Carreras iD, Leander Reinshagen iD, Katharina R Beck iD, Jakob Steinfeldt iD, Marcus Henricsson iD, Pegah Ramezani Rad iD, Lisa Peters iD, Elisabeth T Strässler iD, Joseph Lim iD, Barbara J H Verhaar iD, Yvonne Döring iD und 16 weitere

Arteriosclerosis, Thrombosis, and Vascular Biology · 2025-05 · 45 (5) · 823-839

DOI: 10.1161/atvbaha.124.322346 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2025-05. Verfasst von Vanasa Nageswaran und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité, Campus Benjamin Franklin, Berlin, Germany (V.N., …. Hauptthemen laut MEDLINE: Atherosclerosis, Endothelial Cells, Gastrointestinal Microbiome, Imidazoles. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The microbially produced amino acid–derived metabolite imidazole propionate (ImP) contributes to the pathogenesis of type 2 diabetes. However, the effects of ImP on endothelial cell (EC) physiology and its role in atherosclerotic coronary artery disease are unknown. Using both human and animal model studies, we investigated the potential contributory role of ImP in the development of atherosclerosis. METHODS: Plasma levels of ImP were measured in patients undergoing elective cardiac angiography (n=831) by ultra-high performance liquid chromatography coupled to tandem mass spectrometry. Odds ratios and corresponding 95% confidence intervals for coronary artery disease were calculated based on the ImP quartiles using both univariable and multivariable logistic regression models. The effects of ImP on functional properties of ECs were assessed using HAECs (human aortic endothelial cells). In a mouse model of carotid artery injury, the impact of ImP on vascular regeneration was examined. Additionally, atheroprone Apoe −/− mice fed a high-fat diet were treated with and without ImP (800 µg), and aortic atherosclerotic lesion area was evaluated after 12 weeks. Next-generation sequencing, Western blot analysis, small interfering RNA–based gene knockdown, and tamoxifen-inducible Cre-loxP experiments were performed to investigate ImP-mediated molecular mechanisms. RESULTS: Plasma ImP levels in subjects undergoing cardiac evaluation were associated with increased risk of prevalent coronary artery disease. We found that ImP dose dependently impaired migratory and angiogenic properties of human ECs and promoted an increased inflammatory response. Long-term exposure to ImP compromised the repair potential of the endothelium after an arterial insult. In atheroprone Apoe −/− (apolipoprotein E −/− ) mice, ImP increased atherosclerotic lesion size. Mechanistically, ImP attenuated insulin receptor signaling by suppressing the PI3K (phosphoinositide 3-kinase)/AKT pathway leading to sustained activation of the FOXO1 (forkhead box protein O1) transcription factor. Genetic inactivation of endothelial FOXO1 signaling in ImP-treated mice enhanced the angiogenic activity and preserved the vascular repair capacity of ECs after carotid injury. CONCLUSIONS: Our findings reveal a hitherto unknown role of the microbially produced histidine-derived metabolite ImP in endothelial dysfunction and atherosclerosis, suggesting that ImP metabolism is a potential therapeutic target in atherosclerotic cardiovascular disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisEndothelial CellsGastrointestinal MicrobiomeImidazolesPropionatesCoronary Artery DiseaseAortic DiseasesCarotid Artery DiseasesAnimalsHumansMaleMice, Knockout, ApoEDisease Models, AnimalFemaleMice, Inbred C57BLCells, CulturedMiddle AgedPlaque, AtheroscleroticAgedCell MovementSignal TransductionMiceCarotid Artery Injuries

Stichwörter der Autor:innen

atherosclerotic coronary artery diseaseendothelial cell functionforkhead box protein O1imidazole propionatevascular injury

Substanzen

ImidazolesPropionates

Autor:innen und Institutionen

  • Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité, Campus Benjamin Franklin, Berlin, Germany (V.N., L.R., J.S., P.R.R., E.T.S., N.K., U.L., A.H.).
  • German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Germany (V.N., L.R., P.R.R., L.P., E.T.S., N.K., M.P., W.M.K., U.L., A.H.).
  • Friede Springe-Cardiovascular Prevention Center at Charité, Charité-Universitätsmedizin Berlin, Germany (V.N., J.S., E.S.-T., N.K., U.L., A.H.).
  • Institute of Chemistry and Biochemistry, Freie Universität Berlin, Germany (V.N., P.K.).
  • University Hospital St. Josef-Hospital Bochum, Cardiology and Rhythmology, Ruhr University Bochum, Germany (V.N., L.R., A.H.).
  • Department of Molecular and Clinical Medicine, Wallenberg Laboratory, Sahlgrenska University Hospital, University of Gothenburg, Sweden (A.C., K.R.B., M.H., F.B.).

ORCID-Profile: Vanasa Nageswaran, Alba Carreras, Leander Reinshagen, Katharina R Beck, Jakob Steinfeldt, Marcus Henricsson, Pegah Ramezani Rad, Lisa Peters, Elisabeth T Strässler, Joseph Lim, Barbara J H Verhaar, Yvonne Döring, Christian Weber, Maximilian König, Elisabeth Steinhagen-Thiessen, Ilja Demuth, Nicolle Kränkel, David M Leistner, Petra Knaus, Wolfgang M Kuebler, Marc Ferrell, Ina Nemet, Stanley L Hazen, Ulf Landmesser, Fredrik Bäckhed, Arash Haghikia

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Nageswaran, V., Carreras, A., Reinshagen, L., Beck, K. R., Steinfeldt, J., Henricsson, M., Ramezani Rad, P., Peters, L., Strässler, E. T., Lim, J., Verhaar, B. J. H., Döring, Y., Weber, C., König, M., Steinhagen-Thiessen, E., Demuth, I., Kränkel, N., Leistner, D. M., Potente, M., …, & Haghikia, A. (2025). Gut Microbial Metabolite Imidazole Propionate Impairs Endothelial Cell Function and Promotes the Development of Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 45(5), 823-839. https://doi.org/10.1161/atvbaha.124.322346

Vancouver

Nageswaran V, Carreras A, Reinshagen L, Beck KR, Steinfeldt J, Henricsson M, et al. Gut Microbial Metabolite Imidazole Propionate Impairs Endothelial Cell Function and Promotes the Development of Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 2025;45(5):823-839. doi:10.1161/atvbaha.124.322346

BibTeX
@article{Nageswaran2025,
  author = {Nageswaran, Vanasa and Carreras, Alba and Reinshagen, Leander and Beck, Katharina R and Steinfeldt, Jakob and Henricsson, Marcus and Ramezani Rad, Pegah and Peters, Lisa and Strässler, Elisabeth T and Lim, Joseph and Verhaar, Barbara J H and Döring, Yvonne and Weber, Christian and König, Maximilian and Steinhagen-Thiessen, Elisabeth and Demuth, Ilja and Kränkel, Nicolle and Leistner, David M and Potente, Michael and Nieuwdorp, Max and Knaus, Petra and Kuebler, Wolfgang M and Ferrell, Marc and Nemet, Ina and Hazen, Stanley L and Landmesser, Ulf and Bäckhed, Fredrik and Haghikia, Arash},
  title = {Gut Microbial Metabolite Imidazole Propionate Impairs Endothelial Cell Function and Promotes the Development of Atherosclerosis},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2025},
  volume = {45},
  number = {5},
  pages = {823--839},
  doi = {10.1161/atvbaha.124.322346}
}
Kostenlos starten →